Ekso Bionics Holdings, Inc.
EKSO
$12.40
$0.403.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.22% | 6.26% | 10.78% | 24.20% | 25.45% |
| Total Depreciation and Amortization | -2.18% | -7.43% | -5.97% | -6.51% | -5.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.05% | -45.86% | -92.62% | -23.56% | 18.33% |
| Change in Net Operating Assets | 19.29% | 63.93% | 110.23% | 15.07% | -333.10% |
| Cash from Operations | -19.86% | 10.94% | 17.65% | 26.19% | 18.32% |
| Capital Expenditure | -408.11% | -40.68% | -16.18% | 68.29% | 76.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -408.11% | -40.68% | -16.18% | 68.29% | 76.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -160.00% | -159.79% | -33.26% | -99.68% | -299.36% |
| Issuance of Common Stock | -11.30% | -50.73% | 108.94% | 92.03% | 1,264.75% |
| Repurchase of Common Stock | -2,300.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.67% | -59.74% | 127.86% | 90.79% | 2,132.47% |
| Foreign Exchange rate Adjustments | 216.13% | 210.00% | 257.14% | 96.30% | -29.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.21% | -238.60% | 91.34% | 90.04% | 81.96% |